BioCentury
ARTICLE | Company News

Oxford Gene sales and marketing update

May 12, 2014 7:00 AM UTC

Oxford launched its SureSeq Solid Tumor Panel to profile the mutations of patient tumors for 60 cancer-associated genes. The panel, which includes the full coding regions of the genes, was research-va...